You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
COOL LINK(08491.HK)擬收購一家分銷醫療健康產品公司
格隆匯 03-24 18:40

格隆匯3月24日丨COOL LINK(08491.HK)公佈,繼先前收購事項後,於2020年3月24日,集團與Kam WanLung博士(賣方)訂立買賣協議,內容有關收購一間在香港註冊成立的公司。標的公司的主要業務為買賣及分銷醫療健康相關產品,包括分別於歐洲Qarad BVBA獲CE認證及於中國國家藥品監督管理局(NMPA)正式註冊的SARS-CoV-2抗體檢測試劑盒。

根據製造商進行的產品臨牀性能試驗,結果顯示檢測試劑盒靈敏度和特異度的總一致率為91.61%(95%CI:89.10%~93.58%)。

公司稱,鑑於近期新型冠狀病毒疾病(COVID-19)的爆發規模擴散以及對健康問題的日益關注,公司認為,市場對檢測試劑盒的需求迫在眉睫。董事認為,公司與目標公司開展合作,能更有效地擴展及推廣新型冠狀病毒抗體檢測產品,擴大其受眾範圍。

通過訂立收購事項,集團可開拓業務領域,透過提供一站式醫療服務及產品與該等先前收購事項所述業務互為補充並與該等先前收購事項產生協同效應,同時肩負其企業社會責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account